Aberdeen Group plc - 31 Dec 2025 SCHEDULE 13G Report for Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Filing Manager
Aberdeen Group plc
Reporting Manager
Aberdeen Group plc
Security
Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing Thirty-five (35) Ordinary Shares, no par value per share
Symbol
QNRX
Shares outstanding
838,926 shares
Disclosed Ownership
75,000 shares
Ownership
8.9%
Form type
SCHEDULE 13G
Filing time
28 Jan 2026, 11:05:39 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Aberdeen Group plc 8.9% 75,000 0 75,000 J. Clarke Jenny Clarke/Major Shareholding Reporting Analyst
abrdn Inc. 8.9% 75,000 0 75,000 J. Clarke Jenny Clarke/Major Shareholding Reporting Analyst